Endolaser Treatment of the Ciliary Body for Severe Glaucoma

Marco A. Zarbin, Ronald G. Michels, Serge de Bustros, Harry A. Quigley, Arun Patel

Research output: Contribution to journalArticlepeer-review


Endolaser photocoagulation of the ciliary body was used to treat 42 eyes with severe glaucoma that could not be managed successfully by medical therapy and conventional glaucoma surgery. Follow-up ranged from 6 to 36 months (mean, 13 months). The preoperative intraocular pressure (IOP) ranged from 13 to 76 mmHg (mean, 37 mmHg). The postoperative IOP ranged from 1 to 44 mmHg (mean, 17 mmHg), representing an absolute decrease of 20 mmHg, and a mean decrease of 48%. After one or two (7 eyes) treatment sessions, 11 eyes (26%) had an IOP less than 21 mmHg without medications; 21 eyes (50%) had an IOP less than 21 mmHg with medications; 5 eyes (12%) had an IOP of 21 to 25 mmHg with or without medications; and 5 eyes (12%) had an IOP greater than 25 mmHg. Postoperatively, the number of antiglaucoma medications required was reduced from a mean of 2.8 ± 0.13 to a mean of 1.4 ± 0.19. Twenty-three (72%) of 32 patients were able to discontinue carbonic anhydrase inhibitors.

Original languageEnglish (US)
Pages (from-to)1639-1648
Number of pages10
Issue number12
StatePublished - Jan 1 1988


  • ciliary body
  • endolaser
  • endophotocoagulation
  • glaucoma
  • laser
  • vitrectomy
  • vitreous surgery

ASJC Scopus subject areas

  • Ophthalmology


Dive into the research topics of 'Endolaser Treatment of the Ciliary Body for Severe Glaucoma'. Together they form a unique fingerprint.

Cite this